The board of directors (the “Board”) of Sands China Ltd. (the “Company”) announced that: (A)Mr. Sheldon Gary Adelson (“Mr. Adelson”) will take a medical leave of absence from his positions as the Chairman, Chief Executive Officer and the Chairman of the Nomination Committee of the Company to receive further treatment for lymphoma, and is re-designated as a Non-Executive Director of the Company, in each case, with effect from January 7, 2021. During the leave of absence and after the re-designation, Mr. Adelson will be a Non-Executive Director of the Company. (B)Mr. Robert Glen Goldstein (“Mr. Goldstein”) is appointed as the Acting Chairman, Acting Chief Executive Officer, Acting Chairman of the Nomination Committee, and re-designated as an Executive Director of the Company, in each case, with effect from January 7, 2021. (C)Mr. Chum Kwan Lock, Grant (“Mr. Chum”) is appointed as an Executive Director of the Company with effect from January 7, 2021. Mr. Adelson has confirmed that he has no disagreement with the Board, and there are no matters that need to be brought to the attention of the holders of securities of the Company in respect of his leave of absence and re-designation.